Synfacts, Table of Contents Synfacts 2022; 18(08): 0838DOI: 10.1055/s-0041-1738230 Synthesis of Natural Products and Potential Drugs Synthesis of a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Contributor(s): Philip Kocienski Recommend Article Abstract Buy Article Key words Key wordsS-217622 - COVID-19 - SARS-CoV-2 3CL protease inhibitor Full Text